This international, peer-reviewed Open Access journal by Dove Medical Press focuses on the design and development of drugs, as well as the clinical outcomes, patient safety, and programs targeted at the effective and safe use of medicines. Sign up for email alerts here.
88,007 Monthly downloads/views I 4.319 Impact Factor I 6.6 CiteScore I 1.12 Source Normalized Impact per Paper (SNIP) I 0.784 Scimago Journal & Country Rank (SJR)
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Paller CJ, Antonarakis ES. Cabazitaxel: a novel second-line treatment for metastatic
castration-resistant prostate cancer. Drug Design, Development and Therapy. 2011;5:117–124.
The drug Jevtana was incorrectly named Jentava in Table 4.